Cornel Popovici - Publications
2010
Coffin-Siris syndrome with multiple congenital malformations and intrauterine death: Towards a better delineation of the severe end of the spectrum.
Coulibaly B, Sigaudy S, Girard N, Popovici C, Missirian C, Heckenroth H, Tasei AM, Fernandez C. European Journal of Medical Genetics, 2010, in press.
Syndromic mental retardation with thrombocytopenia due to 21q22.11q22.12 deletion: Report of three patients.
Katzaki E, Morin G, Pollazzon M, Papa FT, Buoni S, Hayek J, Andrieux J, Lecerf L, Popovici C, Receveur A, Mathieu-Dramard M, Renieri A, Mari F, Philip N. American Journal of Medical Genetics, 2010, 152A:1711-1717.
2008
Y253H mutation appearing in a micro-BCR-ABL (e19a2) CML.
Popovici C, Charbonnier A, Gisserot O, Aguilon P, Rémy V, Olschwang S, Mozziconacci MJ. Leukemia Research, 2008, 32:361-362.
2007
Nectin-4 is a new histological and serological tumor associated marker for breast cancer.
Fabre-Lafay S, Monville F, Garrido-Urbani S, Berruyer-Pouyet C, Ginestier C, Reymond N, Finetti P, Sauvan R, Adélaïde J, Geneix J, Lecocq E, Popovici C, Dubreuil P, Viens P, Gonçalves A, Charafe-Jauffret E, Jacquemier J, Birnbaum D, Lopez M. BMC Cancer, 2007, 7:73.
2006
Direct and heterologous approaches to identify the LET-756/FGF interactome.
Popovici C, Berda Y, Conchonaud F, Harbis A, Birnbaum D, Roubin R. BMC Genomics, 2006, 7:105.
Intracellular trafficking of LET-756, a fibroblast growth factor of C. elegans, is controlled by a balance of export and nuclear signals.
Popovici C, Fallet M, Marguet D, Birnbaum D, Roubin R. Experimental Cell Research, 2006, 312:1484-1495.
2005
E6a2 BCR-ABL fusion with BCR exon 5-deleted transcript in a Philadelphia positive CML responsive to Imatinib.
Popovici C, Cailleres S, David M, Lafage-Pochitaloff M, Sainty D, Mozziconacci MJ. Leukemia and Lymphoma, 2005, 46:1375-1377.
An evolutionary history of the FGF superfamily.
Popovici C, Roubin R, Coulier F, Birnbaum D. Bioessays, 2005, 27:849-857.
Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
Murati A, Arnoulet C, Lafage-Pochitaloff M, Adélaide J, Derré M, Slama B, Delaval B, Popovici C, Vey N, Xerri L, Mozziconacci MJ, Boulat O, Sainty D, Birnbaum D, Chaffanet M. International Journal of Oncology, 2005, 26:1485-1492.
A pair as a minimum: the two fibroblast growth factors of the nematode Caenorhabditis elegans.
Birnbaum D, Popovici C, Roubin R. Developmental Dynamics, 2005, 232:247-255.
2004
Functional phylogeny relates LET-756 to fibroblast growth factor 9.
Popovici C, Conchonaud F, Birnbaum D, Roubin R. Journal of Biochemical Chemistry, 2004, 279:40146-40152.
Variant MYST4-CBP gene fusion in a t(10;16) acute myeloid leukaemia.
Murati A, Adélaïde J, Mozziconacci MJ, Popovici C, Carbuccia N, Letessier A, Birg F, Birnbaum D, Chaffanet M. British Journal of Haematology, 2004, 125:601-604.
Phylogenetic analysis of Ciona intestinalis gene superfamilies supports the hypothesis of successive gene expansions.
Leveugle M, Prat K, Popovici C, Birnbaum D, Coulier F. Journal of Molecular Evolution, 2004, 58:168-181.
2003
Neural tissue in ascidian embryos is induced by FGF9/16/20, acting via a combination of maternal GATA and Ets transcription factors.
Bertrand V, Hudson C, Caillol D, Popovici C, Lemaire P. Cell, 2003, 115:615-627.
Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer.
Ginestier C, Bardou VJ, Popovici C, Charafe-Jauffret E, Bertucci F, Geneix J, Adélaïde J, Chaffanet M, Hassoun J, Viens P, Jacquemier J, Birnbaum D. International Journal of Cancer, 2003, 107:854-862.
Chromosome arm 8p and cancer: a fragile hypothesis.
Birnbaum D, Adélaïde J, Popovici C, Charafe-Jauffret E, Mozziconacci MJ, Chaffanet M. Lancet Oncology, 2003, 4:639-642.
A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusion.
Murati A, Adélaïde J, Popovici C, Mozziconacci MJ, Arnoulet C, Lafage-Pochitaloff M, Sainty D, Birnbaum D, Chaffanet M. International Journal of Molecular Medicine, 2003, 12:423-428.
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
Adélaïde J, Huang HE, Murati A, Alsop AE, Orsetti B, Mozziconacci MJ, Popovici C, Ginestier C, Letessier A, Basset C, Courtay-Cahen C, Jacquemier J, Theillet C, Birnbaum D, Edwards PA, Chaffanet M. Genes Chromosomes Cancer, 2003, 37:333-345.
Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).
Guasch G, Popovici C, Mugneret F, Chaffanet M, Pontarotti P, Birnbaum D, Pébusque MJ. Blood, 2003, 101:286-288.
2002
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene.
Popovici C, Basset C, Bertucci F, Orsetti B, Adélaide J, Mozziconacci MJ, Conte N, Murati A, Ginestier C, Charafe-Jauffret E, Ethier SP, Lafage-Pochitaloff M, Theillet C, Birnbaum D, Chaffanet M. Genes Chromosomes Cancer, 2002, 35:204-218.
Caenorhabditis elegans receptors related to mammalian vascular endothelial growth factor receptors are expressed in neural cells.
Popovici C, Isnardon D, Birnbaum D, Roubin R. Neuroscience Letters, 2002, 329:116-120.
2001
Coparalogy: physical and functional clusterings in the human genome.
Popovici C, Leveugle M, Birnbaum D, Coulier F. Biochemica Biophyscia Research Communications, 2001, 288:362-370.
Homeobox gene clusters and the human paralogy map.
Popovici C, Leveugle M, Birnbaum D, Coulier F. FEBS Letters, 2001, 491:237-242.
2000
[FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12]
Pébusque MJ, Chaffanet M, Popovici C, Birnbaum D. Bulletin du Cancer, 2000, 87:887-894.
MetaHox gene clusters.
Coulier F, Popovici C, Villet R, Birnbaum D. Journal of Experimental Zoology, 2000, 288:345-351.
Assignment of the centrosomal protein 110 gene (Cep110) to mouse chromosome bands 2B-C1 by in situ hybridization.
Popovici C, Mattéi MG, Rattner JB, Birnbaum D, Pébusque MJ. Cytogenetics and Cell Genetics, 2000, 89:216-217.
Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line.
Adélaïde J, Chaffanet M, Mozziconacci MJ, Popovici C, Conte N, Fernandez F, Sobol H, Jacquemier J, Pébusque M, Ron D, Lafage-Pochitaloff M, Birnbaum D. International Journal of Oncology, 2000, 16:683-688.
FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33).
Guasch G, Mack GJ, Popovici C, Dastugue N, Birnbaum D, Rattner JB, Pébusque MJ. Blood, 2000, 95:1788-1796.
1999
let-756, a C. elegans fgf essential for worm development.
Roubin R, Naert K, Popovici C, Vatcher G, Coulier F, Thierry-Mieg J, Pontarotti P, Birnbaum D, Baillie D, Thierry-Mieg D. Oncogene, 1999, 18:6741-6747.
The family of Caenorhabditis elegans tyrosine kinase receptors: similarities and differences with mammalian receptors.
Popovici C, Roubin R, Coulier F, Pontarotti P, Birnbaum D. Genome Research, 1999, 9:1026-1039.
The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1.
Popovici C, Zhang B, Grégoire MJ, Jonveaux P, Lafage-Pochitaloff M, Birnbaum D, Pébusque MJ. Blood, 1999, 93:1381-1389.
1998
Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer.
Adélaïde J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, van Alewijk D, Trapman J, Zeillinger R, Børresen-Dale AL, Lidereau R, Birnbaum D, Pébusque MJ. Genes Chromosomes Cancer, 1998, 22:186-199.
Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).
Popovici C, Adélaïde J, Ollendorff V, Chaffanet M, Guasch G, Jacrot M, Leroux D, Birnbaum D, Pébusque MJ. Proc Natl Acad Sci USA, 1998, 95:5712-5717.
t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.
Chaffanet M, Popovici C, Leroux D, Jacrot M, Adélaïde J, Dastugue N, Grégoire MJ, Hagemeijer A, Lafage-Pochitaloff M, Birnbaum D, Pébusque MJ. Oncogene, 1998, 16:945-949.